Patents by Inventor Shankar Kumar

Shankar Kumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7785638
    Abstract: Disclosed herein an herbal acne control compositions comprising extracts of Swietenia mahagoni, Salix tetrasperma, Aloe vera and Curcuma longa and pharmaceutically acceptable excipients. Also disclosed are the methods of making the composition, formulating the same into different delivery systems and use thereof for the prevention of acne related skin disorders in human beings.
    Type: Grant
    Filed: July 25, 2008
    Date of Patent: August 31, 2010
    Assignee: Himalaya Global Holdings, Ltd
    Inventors: Shankar Kumar Mitra, Ekta Saxena, Uddagiri Venkanna Babu
  • Patent number: 7785637
    Abstract: Disclosed is a novel herbal composition for maintaining/caring the skin around the eye, the composition comprising extracts of Saxifraga ligulata syn. Bergenia ligulata, Cipadessa baccifera and Emblica officinalis and cosmeceutical excipients thereof. Also disclosed is a method of extraction, delivery system comprising the same and use thereof.
    Type: Grant
    Filed: June 8, 2007
    Date of Patent: August 31, 2010
    Assignee: Himalaya Global Holdings Ltd.
    Inventors: Shankar Kumar Mitra, Ekta Saxena, Uddagiri Venkanna Babu
  • Publication number: 20100196315
    Abstract: The present invention encompasses IL-12p40 binding proteins, particularly antibodies that bind human interleukin-12 (hIL-12) and/or human IL-23 (hIL-23). Specifically, the invention relates to antibodies that are chimeric, CDR grafted and humanized antibodies. Preferred antibodies have high affinity for hIL-12 and/or hIL-23 and neutralize h IL-12 and/or hIL-23 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Method of making and method of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and/or hIL-23 and for inhibiting hIL-12 and/or hIL-23 activity, e.g., in a human subject suffering from a disorder in which hIL-12 and/or hIL-23 activity is detrimental.
    Type: Application
    Filed: April 19, 2010
    Publication date: August 5, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Susan E. LACY, Emma FUNG, Jonathan P. BELK, Richard W. DIXON, Michael ROGUSKA, Paul R. HINTON, Shankar KUMAR
  • Patent number: 7700739
    Abstract: The present invention encompasses IL-12p40 binding proteins, particularly antibodies that bind human interleukin-12 (hIL-12) and/or human IL-23 (hIL-23). Specifically, the invention relates to antibodies that are chimeric, CDR grafted and humanized antibodies. Preferred antibodies have high affinity for hIL-12 and/or hIL-23 and neutralize h IL-12 and/or hIL-23 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Method of making and method of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and/or hIL-23 and for inhibiting hIL-12 and/or hIL-23 activity, e.g., in a human subject suffering from a disorder in which hIL-12 and/or hIL-23 activity is detrimental.
    Type: Grant
    Filed: June 29, 2006
    Date of Patent: April 20, 2010
    Assignee: Abbott Laboratories
    Inventors: Susan E. Lacy, Emma Fung, Jonathan P. Belk, Richard W. Dixon, Michael Roguska, Paul R. Hinton, Shankar Kumar
  • Publication number: 20100047245
    Abstract: The present invention encompasses IL-12p40 binding proteins, particularly antibodies that bind human interleukin-12 (hIL-12) and/or human IL-23 (hIL-23). Specifically, the invention relates to antibodies that are chimeric, CDR grafted and humanized antibodies. Preferred antibodies have high affinity for hIL-12 and/or hIL-23 and neutralize h IL-12 and/or hIL-23 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Method of making and method of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and/or hIL-23 and for inhibiting hIL-12 and/or hIL-23 activity, e.g., in a human subject suffering from a disorder in which hIL-12 and/or hIL-23 activity is detrimental.
    Type: Application
    Filed: June 29, 2006
    Publication date: February 25, 2010
    Inventors: Susan E. Lacy, Emma Fung, Jonathan P. Belk, Richard W. Dixon, Michael Roguska, Paul R. Hinton, Shankar Kumar
  • Publication number: 20100040709
    Abstract: Disclosed is a natural herbal composition for preventing wrinkles and other skin disorders due to aging, stress and environmental factors without any side effect. The composition comprises extracts of Rhodomyrtus tomentosa, Cipadessa baccifera, Woodfordia fruticosa and Camellia sinensis.
    Type: Application
    Filed: September 12, 2006
    Publication date: February 18, 2010
    Applicant: HIMALAYA GLOBAL HOLDINGS, LTD.
    Inventors: Shankar Kumar Mitra, Ekta Saxena
  • Publication number: 20100004920
    Abstract: Methods, systems, and apparatus, including computer program products, for language translation are disclosed. In one implementation, a method is provided. The method includes accessing a hypothesis space, where the hypothesis space represents a plurality of candidate translations; performing decoding on the hypothesis space to obtain a translation hypothesis that minimizes an expected error in classification calculated relative to an evidence space; and providing the obtained translation hypothesis for use by a user as a suggested translation in a target translation.
    Type: Application
    Filed: July 2, 2009
    Publication date: January 7, 2010
    Applicant: GOOGLE INC.
    Inventors: Wolfgang Macherey, Franz Josef Och, Shankar Kumar, Roy W. Tromble
  • Publication number: 20090299038
    Abstract: The present invention provides antibodies specifically against hDlk-1 and having anti-tumor activity in vivo (anti-hDlk-1 antibodies), a fragments of the antibodies, hybridomas that produce the antibodies, a complex of the antibody or antibody fragment and an agent, a pharmaceutical composition comprising the antibody and the like, a tumor therapeutic agent, a tumor angiogenesis inhibitor, a tumor diagnostic agent, a method for detecting tumor, a kit for detecting and/or diagnosing tumor, etc.
    Type: Application
    Filed: March 16, 2009
    Publication date: December 3, 2009
    Applicant: LivTech Inc.
    Inventors: Koji Nakamura, Rie Tajima, Shankar Kumar, J. Yun Tso, Naoya Tsurushita
  • Publication number: 20090238900
    Abstract: Disclosed is an herbal composition for the treatment of Type II diabetes and their associated secondary complications in humans, wherein said composition comprising extract of roots of Cipadessa baccifera and pharmaceutically acceptable excipients, method for preparing the same and use thereof. The anti-diabetic herbal composition disclosed herein is effective to reduce the glucose, triglyceride levels in blood or other complications related to Type-II diabetes and its secondary complications thereof.
    Type: Application
    Filed: August 27, 2008
    Publication date: September 24, 2009
    Applicant: HIMALAYA GLOBAL HOLDINGS LIMITED
    Inventors: Shankar Kumar Mitra, Ekta Saxena, Uddagiri Venkanna Babu
  • Patent number: 7591913
    Abstract: The present invention generally provides methods of improving thermoelectric properties of alloys by subjecting them to one or more high temperature annealing steps, performed at temperatures at which the alloys exhibit a mixed solid/liquid phase, followed by cooling steps. For example, in one aspect, such a method of the invention can include subjecting an alloy sample to a temperature that is sufficiently elevated to cause partial melting of at least some of the grains. The sample can then be cooled so as to solidify the melted grain portions such that each solidified grain portion exhibits an average chemical composition, characterized by a relative concentration of elements forming the alloy, that is different than that of the remainder of the grain.
    Type: Grant
    Filed: April 6, 2005
    Date of Patent: September 22, 2009
    Assignees: Massachusetts Institute of Technology, The Trustees of Boston College
    Inventors: Zhifeng Ren, Gang Chen, Shankar Kumar, Hohyun Lee
  • Patent number: 7586033
    Abstract: The present invention generally relates to binary or higher order semiconductor nanoparticles doped with a metallic element, and thermoelectric compositions incorporating such nanoparticles. In one aspect, the present invention provides a thermoelectric composition comprising a plurality of nanoparticles each of which includes an alloy matrix formed of a Group IV element and Group VI element and a metallic dopant distributed within the matrix.
    Type: Grant
    Filed: May 3, 2005
    Date of Patent: September 8, 2009
    Assignees: Massachusetts Institute of Technology, The Trustees of Boston College
    Inventors: Zhifeng Ren, Gang Chen, Bed Poudel, Shankar Kumar, Wenzhong Wang, Mildred Dresselhaus
  • Publication number: 20090220623
    Abstract: Disclosed herein a novel herbal acne control compositions comprising extracts of Swietenia mahagoni, Salix tetrasperma, Aloe vera and Curcuma longa and pharmaceutically acceptable excipients. Also disclosed are the methods of making the composition, formulating the same into different delivery systems and use thereof for the prevention of acne related skin disorders in human beings.
    Type: Application
    Filed: July 25, 2008
    Publication date: September 3, 2009
    Applicant: HIMALAYA GLOBAL HOLDINGS LIMITED
    Inventors: Shankar Kumar Mitra, Ekta Saxena, Uddagiri Venkanna Babu
  • Publication number: 20090185987
    Abstract: Disclosed herein is a herbal dental care composition comprising extracts of herbs Punica granatum, Acacia Arabica, Terminalia chebula, Terminalia bellerica, Emblica officinalis and Embelia ribes, optionally extract of Azadirachta indica and pharmaceutical acceptable excipients. Also disclosed are the methods of making the composition, formulating the same into different delivery systems and use thereof for preventing various dental diseases.
    Type: Application
    Filed: June 13, 2008
    Publication date: July 23, 2009
    Applicant: HIMALAYA GLOBAL HOLDINGS LTD.
    Inventors: Shankar Kumar Mitra, Ramesh Suriyanarayanan, Uddagiri Venkanna Babu, Ekta Saxena
  • Publication number: 20090155262
    Abstract: This invention relates to the diagnosis and treatment of cancerous diseases, particularly to the mediation of cytotoxicity of tumor cells; and most particularly to the use of cancerous disease modifying antibodies (CDMAB), optionally in combination with one or more chemotherapeutic agents, as a means for initiating the cytotoxic response. The invention further relates to binding assays which utilize the CDMAB of the instant invention.
    Type: Application
    Filed: September 18, 2008
    Publication date: June 18, 2009
    Inventors: David S. F. Young, Helen P. Findlay, Susan E. Hahn, Luis A. G. da Cruz, Daad Sayegh, Kristian Rogers, Shankar Kumar, Paul Hinton
  • Publication number: 20090149167
    Abstract: Connected Portfolio Services for use in a mobile phone network include new mobile phone services: Scheduled Conference with Dial-Out and Dial-In modes of operation; Reservationless Conference; Instant Conferencing; Group Short Message Service with Reply All; Voice Short Message Service with Reply All; Family Connect; Buddy Connect; Quick Reach; and Email2Conference. Connected Portfolio Services also include a new handset client application, management of a limited pool of network routable numbers, and a prepaid billing solution.
    Type: Application
    Filed: October 27, 2008
    Publication date: June 11, 2009
    Applicant: KODIAK NETWORKS, INC.
    Inventors: Krishnakant M. Patel, Gorachand Kundu, Ravi Ayyasamy, Bruce D. Lawler, Ravi Shankar Kumar, Harisha Mahabaleshwara Negalaguli, Basem Ahmad Ardah, Pratap Chandana, Shan-Jen Chiou, Arun Velayudhan, Ramu Kandula
  • Publication number: 20090136602
    Abstract: A natural immunostimulant composition for the treatment of immunodeficiency, the composition comprising extract of plant Symplocos racemosa and/or plant Prosopis glandulosa and a pharmaceutically acceptable carrier is disclosed. Also disclosed are methods for obtaining the plant extract, methods for preparing the composition and methods of treating diseases related to immunodeficiency.
    Type: Application
    Filed: February 2, 2009
    Publication date: May 28, 2009
    Applicant: MMI Corporation
    Inventors: Shankar Kumar MITRA, Ekta Saxena, Mallikarjun Narayan Dixit
  • Patent number: 7442777
    Abstract: This invention relates to the diagnosis and treatment of cancerous diseases, particularly to the mediation of cytotoxicity of tumor cells; and most particularly to the use of cancerous disease modifying antibodies (CDMAB), optionally in combination with one or more chemotherapeutic agents, as a means for initiating the cytotoxic response. The invention further relates to binding assays which utilize the CDMAB of the instant invention.
    Type: Grant
    Filed: February 24, 2006
    Date of Patent: October 28, 2008
    Assignee: Arius Research Inc.
    Inventors: David S. F. Young, Helen P. Findlay, Susan E. Hahn, Luis A. G. da Cruz, Daad Sayegh, Kristian Rogers, Shankar Kumar, Paul Hinton
  • Patent number: 7435430
    Abstract: Disclosed is a natural sedative composition for the treatment of insomnia, anxiety, stress and all kinds of sleep disorders, the composition comprising extract of plant Myristica fragrans and/or plant Hedychium spicatum and a pharmaceutically acceptable carrier. Also disclosed are methods for obtaining the plant extract and dosage forms.
    Type: Grant
    Filed: July 28, 2004
    Date of Patent: October 14, 2008
    Assignee: MMI Corporation
    Inventors: Shankar Kumar Mitra, Ekta Saxena, Marikunte Venkata Ranganna
  • Publication number: 20080226632
    Abstract: The present invention is directed to anti-AR antibodies, preferably humanized monoclonal antibodies having the amino acid sequences disclosed herein. The present invention includes a pharmaceutical composition comprising such antibodies. The present invention includes a method of inhibiting cancer cell growth comprising administering such antibodies into a subject. The present invention also provides a method of treating cancer or psoriasis in a subject in need of such a treatment by administering such antibodies to said subject in a pharmaceutically effective amount.
    Type: Application
    Filed: May 23, 2007
    Publication date: September 18, 2008
    Applicant: PDL BIOPHARMA, INC.
    Inventors: Nicholas F. Landolfi, Naoya Tsurshita, Paul R. Hinton, Shankar Kumar
  • Publication number: 20080175934
    Abstract: Disclosed is a novel herbal composition comprising extract of Quercus infectoria having rich and effective concentration of as antioxidants and phenolic compounds. Further the present invention provides a process for preparing said composition and use thereof in cosmeceuticals, pharmaceuticals and health drinks for treating oxidative stress and other life style diseases.
    Type: Application
    Filed: December 27, 2007
    Publication date: July 24, 2008
    Applicant: Himalaya Global Holdings Limited
    Inventors: Shankar Kumar Mitra, Ekta Saxena, Rangesh Paramesh, Uddagiri Venkanna Babu, Sundaram Ramachandran, Marikunte Venkata Ranganna